{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:21:51Z","timestamp":1793726511623,"version":"4.6.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T00:00:00Z","timestamp":1518998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Economia y Competitividad","doi-asserted-by":"crossref","award":["SAF2010-21058"],"award-info":[{"award-number":["SAF2010-21058"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Economia y Competitividad","doi-asserted-by":"crossref","award":["CSD2008-00005"],"award-info":[{"award-number":["CSD2008-00005"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Economia y Competitividad","doi-asserted-by":"crossref","award":["SAF2013-48983-R"],"award-info":[{"award-number":["SAF2013-48983-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Economia y Competitividad","doi-asserted-by":"crossref","award":["SAF2016-08573-R"],"award-info":[{"award-number":["SAF2016-08573-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministrio de Economia y Competitividad","award":["SAF2013-45888R"],"award-info":[{"award-number":["SAF2013-45888R"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI13\/01250"],"award-info":[{"award-number":["PI13\/01250"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011264","name":"FP7 People: Marie-Curie Actions","doi-asserted-by":"publisher","award":["PIRG08-GA-2010-276957"],"award-info":[{"award-number":["PIRG08-GA-2010-276957"]}],"id":[{"id":"10.13039\/100011264","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s12035-018-0956-5","type":"journal-article","created":{"date-parts":[[2018,2,18]],"date-time":"2018-02-18T23:59:55Z","timestamp":1518998395000},"page":"7728-7742","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Increased Levels of Rictor Prevent Mutant Huntingtin-Induced Neuronal Degeneration"],"prefix":"10.1007","volume":"55","author":[{"given":"Jordi","family":"Creus-Muncunill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ru\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Alcal\u00e1-Vida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Badillos-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Roman\u00ed-Aumedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Alberch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Perez-Ota\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Malagelada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9165-6539","authenticated-orcid":false,"given":"Esther","family":"P\u00e9rez-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,19]]},"reference":[{"key":"956_CR1","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149:274\u2013293","journal-title":"Cell"},{"key":"956_CR2","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/ncb1183","volume":"6","author":"E Jacinto","year":"2004","unstructured":"Jacinto E, Loewith R, Schmidt A, Lin S, Ruegg MA, Hall A, Hall MN (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 6:1122\u20131128","journal-title":"Nat Cell Biol"},{"key":"956_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","volume":"110","author":"DH Kim","year":"2002","unstructured":"Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110:163\u2013175","journal-title":"Cell"},{"key":"956_CR4","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","volume":"14","author":"DD Sarbassov","year":"2004","unstructured":"Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14:1296\u20131302","journal-title":"Curr Biol"},{"key":"956_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrm3025","volume":"12","author":"R Zoncu","year":"2011","unstructured":"Zoncu R, Efeyan A, Sabatini DM (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12:21\u201335","journal-title":"Nat Rev Mol Cell Biol"},{"key":"956_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim J, Kundu M, Viollet B, Guan KL (2011) AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13:132\u2013141","journal-title":"Nat Cell Biol"},{"key":"956_CR7","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.1106148","volume":"307","author":"DD Sarbassov","year":"2005","unstructured":"Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex. Science 307:1098\u20131101","journal-title":"Science"},{"key":"956_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1042\/BJ20081668","volume":"416","author":"JM Garcia-Martinez","year":"2008","unstructured":"Garcia-Martinez JM, Alessi DR (2008) mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J 416:375\u2013385","journal-title":"Biochem J"},{"key":"956_CR9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.devcel.2006.10.007","volume":"11","author":"DA Guertin","year":"2006","unstructured":"Guertin DA, Stevens DM, Thoreen CC, Burds AA, Kalaany NY, Moffat J, Brown M, Fitzgerald KJ et al (2006) Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell 11:859\u2013871","journal-title":"Dev Cell"},{"key":"956_CR10","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.4161\/cc.10.14.16586","volume":"10","author":"WJ Oh","year":"2011","unstructured":"Oh WJ, Jacinto E (2011) mTOR complex 2 signaling and functions. Cell Cycle 10:2305\u20132316","journal-title":"Cell Cycle"},{"key":"956_CR11","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/nn.3546","volume":"16","author":"M Costa-Mattioli","year":"2013","unstructured":"Costa-Mattioli M, Monteggia LM (2013) mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat Neurosci 16:1537\u20131543","journal-title":"Nat Neurosci"},{"key":"956_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neuron.2014.09.034","volume":"84","author":"JO Lipton","year":"2014","unstructured":"Lipton JO, Sahin M (2014) The neurology of mTOR. Neuron 84:275\u2013291","journal-title":"Neuron"},{"key":"956_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3233\/JAD-131124","volume":"38","author":"YX Sun","year":"2014","unstructured":"Sun YX, Ji X, Mao X, Xie L, Jia J, Galvan V, Greenberg DA, Jin K (2014) Differential activation of mTOR complex 1 signaling in human brain with mild to severe Alzheimer\u2019s disease. J Alzheimers Dis 38:437\u2013444","journal-title":"J Alzheimers Dis"},{"key":"956_CR14","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1523\/JNEUROSCI.3696-09.2010","volume":"30","author":"A Sharma","year":"2010","unstructured":"Sharma A, Hoeffer CA, Takayasu Y, Miyawaki T, McBride SM, Klann E, Zukin RS (2010) Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci 30:694\u2013702","journal-title":"J Neurosci"},{"key":"956_CR15","doi-asserted-by":"publisher","first-page":"e1000393","DOI":"10.1371\/journal.pbio.1000393","volume":"8","author":"MA Siuta","year":"2010","unstructured":"Siuta MA, Robertson SD, Kocalis H, Saunders C, Gresch PJ, Khatri V, Shiota C, Kennedy JP et al (2010) Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. PLoS Biol 8:e1000393","journal-title":"PLoS Biol"},{"key":"956_CR16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1083\/jcb.201205030","volume":"201","author":"V Thomanetz","year":"2013","unstructured":"Thomanetz V, Angliker N, Cloetta D, Lustenberger RM, Schweighauser M, Oliveri F, Suzuki N, Ruegg MA (2013) Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology. J Cell Biol 201:293\u2013308","journal-title":"J Cell Biol"},{"key":"956_CR17","doi-asserted-by":"publisher","first-page":"ra103","DOI":"10.1126\/scisignal.2005633","volume":"7","author":"WM Pryor","year":"2014","unstructured":"Pryor WM, Biagioli M, Shahani N, Swarnkar S, Huang WC, Page DT, MacDonald ME, Subramaniam S (2014) Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington\u2019s disease. Sci Signal 7:ra103","journal-title":"Sci Signal"},{"key":"956_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.neuron.2014.12.019","volume":"85","author":"JH Lee","year":"2015","unstructured":"Lee JH, Tecedor L, Chen YH, Monteys AM, Sowada MJ, Thompson LM, Davidson BL (2015) Reinstating aberrant mTORC1 activity in Huntington\u2019s disease mice improves disease phenotypes. Neuron 85:303\u2013315","journal-title":"Neuron"},{"key":"956_CR19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/ng1362","volume":"36","author":"B Ravikumar","year":"2004","unstructured":"Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, Scaravilli F, Easton DF et al (2004) Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 36:585\u2013595","journal-title":"Nat Genet"},{"key":"956_CR20","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"956_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"956_CR22","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.tibs.2013.05.003","volume":"38","author":"J Labbadia","year":"2013","unstructured":"Labbadia J, Morimoto RI (2013) Huntington\u2019s disease: underlying molecular mechanisms and emerging concepts. Trends Biochem Sci 38:378\u2013385","journal-title":"Trends Biochem Sci"},{"key":"956_CR23","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E (2010) Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol Rev 90:905\u2013981","journal-title":"Physiol Rev"},{"key":"956_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00401-007-0306-6","volume":"115","author":"JP Vonsattel","year":"2008","unstructured":"Vonsattel JP (2008) Huntington disease models and human neuropathology: similarities and differences. Acta Neuropathol 115:55\u201369","journal-title":"Acta Neuropathol"},{"key":"956_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3389\/fncel.2014.00295","volume":"8","author":"L Francelle","year":"2014","unstructured":"Francelle L, Galvan L, Brouillet E (2014) Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington\u2019s disease. Front Cell Neurosci 8:295","journal-title":"Front Cell Neurosci"},{"key":"956_CR26","doi-asserted-by":"publisher","first-page":"50514","DOI":"10.1074\/jbc.M309348200","volume":"278","author":"S Gines","year":"2003","unstructured":"Gines S, Ivanova E, Seong IS, Saura CA, MacDonald ME (2003) Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington\u2019s disease knock-in striatal cells. J Biol Chem 278:50514\u201350522","journal-title":"J Biol Chem"},{"key":"956_CR27","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/cdd.2009.127","volume":"17","author":"A Saavedra","year":"2010","unstructured":"Saavedra A, Garcia-Martinez JM, Xifro X, Giralt A, Torres-Peraza JF, Canals JM, Diaz-Hernandez M, Lucas JJ et al (2010) PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K\/Akt pro-survival pathway in Huntington\u2019s disease striatum. Cell Death Differ 17:324\u2013335","journal-title":"Cell Death Differ"},{"key":"956_CR28","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.1093\/hmg\/ddr351","volume":"20","author":"A Giralt","year":"2011","unstructured":"Giralt A, Saavedra A, Carreton O, Xifro X, Alberch J, Perez-Navarro E (2011) Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington\u2019s disease. Hum Mol Genet 20:4232\u20134247","journal-title":"Hum Mol Genet"},{"key":"956_CR29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.nbd.2008.10.009","volume":"33","author":"I Dragatsis","year":"2009","unstructured":"Dragatsis I, Goldowitz D, Del MN, Deng YP, Meade CA, Liu L, Sun Z, Dietrich P et al (2009) CAG repeat lengths > or =335 attenuate the phenotype in the R6\/2 Huntington\u2019s disease transgenic mouse. Neurobiol Dis 33:315\u2013330","journal-title":"Neurobiol Dis"},{"key":"956_CR30","doi-asserted-by":"publisher","first-page":"e1001242","DOI":"10.1371\/journal.pgen.1001242","volume":"6","author":"L Mollersen","year":"2010","unstructured":"Mollersen L, Rowe AD, Larsen E, Rognes T, Klungland A (2010) Continuous and periodic expansion of CAG repeats in Huntington\u2019s disease R6\/1 mice. PLoS Genet 6:e1001242","journal-title":"PLoS Genet"},{"key":"956_CR31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.nbd.2008.11.015","volume":"33","author":"AJ Morton","year":"2009","unstructured":"Morton AJ, Glynn D, Leavens W, Zheng Z, Faull RL, Skepper JN, Wight JM (2009) Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6\/2 mice. Neurobiol Dis 33:331\u2013341","journal-title":"Neurobiol Dis"},{"key":"956_CR32","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van RJ, Rogers D, Coleman SH, Graham RK, Deng Y, Oh R, Bissada N et al (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12:1555\u20131567","journal-title":"Hum Mol Genet"},{"key":"956_CR33","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","volume":"9","author":"F Trettel","year":"2000","unstructured":"Trettel F, Rigamonti D, Hilditch-Maguire P, Wheeler VC, Sharp AH, Persichetti F, Cattaneo E, MacDonald ME (2000) Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum Mol Genet 9:2799\u20132809","journal-title":"Hum Mol Genet"},{"key":"956_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12017-013-8248-8","volume":"16","author":"L Rue","year":"2014","unstructured":"Rue L, Alcala-Vida R, Lopez-Soop G, Creus-Muncunill J, Alberch J, Perez-Navarro E (2014) Early down-regulation of PKCdelta as a pro-survival mechanism in Huntington\u2019s disease. NeuroMolecular Med 16:25\u201337","journal-title":"NeuroMolecular Med"},{"key":"956_CR35","doi-asserted-by":"publisher","first-page":"7265","DOI":"10.1093\/hmg\/ddv426","volume":"24","author":"M Puigdellivol","year":"2015","unstructured":"Puigdellivol M, Cherubini M, Brito V, Giralt A, Suelves N, Ballesteros J, Zamora-Moratalla A, Martin ED et al (2015) A role for Kalirin-7 in corticostriatal synaptic dysfunction in Huntington\u2019s disease. Hum Mol Genet 24:7265\u20137285","journal-title":"Hum Mol Genet"},{"key":"956_CR36","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.bbadis.2016.04.002","volume":"1862","author":"M Anglada-Huguet","year":"2016","unstructured":"Anglada-Huguet M, Giralt A, Rue L, Alberch J, Xifro X (2016) Loss of striatal 90-kDa ribosomal S6 kinase (Rsk) is a key factor for motor, synaptic and transcription dysfunction in Huntington\u2019s disease. Biochim Biophys Acta 1862:1255\u20131266","journal-title":"Biochim Biophys Acta"},{"key":"956_CR37","doi-asserted-by":"publisher","first-page":"8150","DOI":"10.1523\/JNEUROSCI.3446-10.2011","volume":"31","author":"A Saavedra","year":"2011","unstructured":"Saavedra A, Giralt A, Rue L, Xifro X, Xu J, Ortega Z, Lucas JJ, Lombroso PJ et al (2011) Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington's disease: a STEP in the resistance to excitotoxicity. J Neurosci 31:8150\u20138162","journal-title":"J Neurosci"},{"key":"956_CR38","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.nbd.2012.12.008","volume":"52","author":"L Rue","year":"2013","unstructured":"Rue L, Lopez-Soop G, Gelpi E, Martinez-Vicente M, Alberch J, Perez-Navarro E (2013) Brain region- and age-dependent dysregulation of p62 and NBR1 in a mouse model of Huntington\u2019s disease. Neurobiol Dis 52:219\u2013228","journal-title":"Neurobiol Dis"},{"key":"956_CR39","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y et al (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506","journal-title":"Cell"},{"key":"956_CR40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/hmg\/8.1.115","volume":"8","author":"VC Wheeler","year":"1999","unstructured":"Wheeler VC, Auerbach W, White JK, Srinidhi J, Auerbach A, Ryan A, Duyao MP, Vrbanac V et al (1999) Length-dependent gametic CAG repeat instability in the Huntington\u2019s disease knock-in mouse. Hum Mol Genet 8:115\u2013122","journal-title":"Hum Mol Genet"},{"key":"956_CR41","doi-asserted-by":"publisher","first-page":"e47741","DOI":"10.1371\/journal.pone.0047741","volume":"7","author":"T Bashir","year":"2012","unstructured":"Bashir T, Cloninger C, Artinian N, Anderson L, Bernath A, Holmes B, Benavides-Serrato A, Sabha N et al (2012) Conditional astroglial Rictor overexpression induces malignant glioma in mice. PLoS One 7:e47741","journal-title":"PLoS One"},{"key":"956_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11010-015-2406-2","volume":"405","author":"P Chatterjee","year":"2015","unstructured":"Chatterjee P, Seal S, Mukherjee S, Kundu R, Bhuyan M, Barua NC, Baruah PK, Babu SP et al (2015) A carbazole alkaloid deactivates mTOR through the suppression of rictor and that induces apoptosis in lung cancer cells. Mol Cell Biochem 405:149\u2013158","journal-title":"Mol Cell Biochem"},{"key":"956_CR43","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.devcel.2010.03.008","volume":"18","author":"CC Chen","year":"2010","unstructured":"Chen CC, Jeon SM, Bhaskar PT, Nogueira V, Sundararajan D, Tonic I, Park Y, Hay N (2010) FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor. Dev Cell 18:592\u2013604","journal-title":"Dev Cell"},{"key":"956_CR44","doi-asserted-by":"publisher","first-page":"11712","DOI":"10.1158\/0008-5472.CAN-07-2223","volume":"67","author":"J Masri","year":"2007","unstructured":"Masri J, Bernath A, Martin J, Jo OD, Vartanian R, Funk A, Gera J (2007) mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor. Cancer Res 67:11712\u201311720","journal-title":"Cancer Res"},{"key":"956_CR45","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.cmet.2013.09.013","volume":"18","author":"K Masui","year":"2013","unstructured":"Masui K, Tanaka K, Akhavan D, Babic I, Gini B, Matsutani T, Iwanami A, Liu F et al (2013) mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. Cell Metab 18:726\u2013739","journal-title":"Cell Metab"},{"key":"956_CR46","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1074\/jbc.M114.602789","volume":"290","author":"C Zhang","year":"2015","unstructured":"Zhang C, Hwarng G, Cooper DE, Grevengoed TJ, Eaton JM, Natarajan V, Harris TE, Coleman RA (2015) Inhibited insulin signaling in mouse hepatocytes is associated with increased phosphatidic acid but not diacylglycerol. J Biol Chem 290:3519\u20133528","journal-title":"J Biol Chem"},{"key":"956_CR47","doi-asserted-by":"publisher","first-page":"26089","DOI":"10.1074\/jbc.M504045200","volume":"280","author":"MK Holz","year":"2005","unstructured":"Holz MK, Blenis J (2005) Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase. J Biol Chem 280:26089\u201326093","journal-title":"J Biol Chem"},{"issue":"Pt 2","key":"956_CR48","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1042\/bj3440427","volume":"344","author":"BT Nave","year":"1999","unstructured":"Nave BT, Ouwens M, Withers DJ, Alessi DR, Shepherd PR (1999) Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem J 344(Pt 2):427\u2013431","journal-title":"Biochem J"},{"key":"956_CR49","doi-asserted-by":"publisher","first-page":"7866","DOI":"10.1074\/jbc.M109.096222","volume":"285","author":"GA Soliman","year":"2010","unstructured":"Soliman GA, Acosta-Jaquez HA, Dunlop EA, Ekim B, Maj NE, Tee AR, Fingar DC (2010) mTOR Ser-2481 autophosphorylation monitors mTORC-specific catalytic activity and clarifies rapamycin mechanism of action. J Biol Chem 285:7866\u20137879","journal-title":"J Biol Chem"},{"key":"956_CR50","doi-asserted-by":"publisher","first-page":"10189","DOI":"10.1074\/jbc.M210837200","volume":"278","author":"KS Kovacina","year":"2003","unstructured":"Kovacina KS, Park GY, Bae SS, Guzzetta AW, Schaefer E, Birnbaum MJ, Roth RA (2003) Identification of a proline-rich Akt substrate as a 14-3-3 binding partner. J Biol Chem 278:10189\u201310194","journal-title":"J Biol Chem"},{"key":"956_CR51","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1523\/JNEUROSCI.5673-09.2010","volume":"30","author":"Z Ortega","year":"2010","unstructured":"Ortega Z, Diaz-Hernandez M, Maynard CJ, Hernandez F, Dantuma NP, Lucas JJ (2010) Acute polyglutamine expression in inducible mouse model unravels ubiquitin\/proteasome system impairment and permanent recovery attributable to aggregate formation. J Neurosci 30:3675\u20133688","journal-title":"J Neurosci"},{"key":"956_CR52","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.molcel.2010.08.016","volume":"39","author":"D Gao","year":"2010","unstructured":"Gao D, Wan L, Inuzuka H, Berg AH, Tseng A, Zhai B, Shaik S, Bennett E et al (2010) Rictor forms a complex with Cullin-1 to promote SGK1 ubiquitination and destruction. Mol Cell 39:797\u2013808","journal-title":"Mol Cell"},{"key":"956_CR53","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.1158\/0008-5472.CAN-11-0368","volume":"71","author":"A Uesugi","year":"2011","unstructured":"Uesugi A, Kozaki K, Tsuruta T, Furuta M, Morita K, Imoto I, Omura K, Inazawa J (2011) The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res 71:5765\u20135778","journal-title":"Cancer Res"},{"key":"956_CR54","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1074\/jbc.M112.396762","volume":"288","author":"S Venkataraman","year":"2013","unstructured":"Venkataraman S, Birks DK, Balakrishnan I, Alimova I, Harris PS, Patel PR, Handler MH, Dubuc A et al (2013) MicroRNA 218 acts as a tumor suppressor by targeting multiple cancer phenotype-associated genes in medulloblastoma. J Biol Chem 288:1918\u20131928","journal-title":"J Biol Chem"},{"key":"956_CR55","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nrg1328","volume":"5","author":"DP Bartel","year":"2004","unstructured":"Bartel DP, Chen CZ (2004) Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 5:396\u2013400","journal-title":"Nat Rev Genet"},{"key":"956_CR56","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.expneurol.2010.10.012","volume":"227","author":"ST Lee","year":"2011","unstructured":"Lee ST, Chu K, Im WS, Yoon HJ, Im JY, Park JE, Park KH, Jung KH et al (2011) Altered microRNA regulation in Huntington\u2019s disease models. Exp Neurol 227:172\u2013179","journal-title":"Exp Neurol"},{"key":"956_CR57","doi-asserted-by":"publisher","first-page":"7219","DOI":"10.1093\/nar\/gkq575","volume":"38","author":"E Marti","year":"2010","unstructured":"Marti E, Pantano L, Banez-Coronel M, Llorens F, Minones-Moyano E, Porta S, Sumoy L, Ferrer I et al (2010) A myriad of miRNA variants in control and Huntington\u2019s disease brain regions detected by massively parallel sequencing. Nucleic Acids Res 38:7219\u20137235","journal-title":"Nucleic Acids Res"},{"key":"956_CR58","doi-asserted-by":"publisher","first-page":"14341","DOI":"10.1523\/JNEUROSCI.2390-08.2008","volume":"28","author":"AN Packer","year":"2008","unstructured":"Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL (2008) The bifunctional microRNA miR-9\/miR-9* regulates REST and CoREST and is downregulated in Huntington\u2019s disease. J Neurosci 28:14341\u201314346","journal-title":"J Neurosci"},{"key":"956_CR59","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/2050-7771-1-28","volume":"1","author":"D Diamanti","year":"2013","unstructured":"Diamanti D, Mori E, Incarnato D, Malusa F, Fondelli C, Magnoni L, Pollio G (2013) Whole gene expression profile in blood reveals multiple pathways deregulation in R6\/2 mouse model. Biomark Res 1:28","journal-title":"Biomark Res"},{"key":"956_CR60","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.molcel.2007.03.003","volume":"25","author":"Y Sancak","year":"2007","unstructured":"Sancak Y, Thoreen CC, Peterson TR, Lindquist RA, Kang SA, Spooner E, Carr SA, Sabatini DM (2007) PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell 25:903\u2013915","journal-title":"Mol Cell"},{"key":"956_CR61","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/ncb1547","volume":"9","author":"HE Vander","year":"2007","unstructured":"Vander HE, Lee SI, Bandhakavi S, Griffin TJ, Kim DH (2007) Insulin signalling to mTOR mediated by the Akt\/PKB substrate PRAS40. Nat Cell Biol 9:316\u2013323","journal-title":"Nat Cell Biol"},{"key":"956_CR62","doi-asserted-by":"publisher","first-page":"20036","DOI":"10.1074\/jbc.M702376200","volume":"282","author":"L Wang","year":"2007","unstructured":"Wang L, Harris TE, Roth RA, Lawrence JC Jr (2007) PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. J Biol Chem 282:20036\u201320044","journal-title":"J Biol Chem"},{"key":"956_CR63","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/hmg\/dds414","volume":"22","author":"RP Carson","year":"2013","unstructured":"Carson RP, Fu C, Winzenburger P, Ess KC (2013) Deletion of Rictor in neural progenitor cells reveals contributions of mTORC2 signaling to tuberous sclerosis complex. Hum Mol Genet 22:140\u2013152","journal-title":"Hum Mol Genet"},{"key":"956_CR64","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nn.3351","volume":"16","author":"W Huang","year":"2013","unstructured":"Huang W, Zhu PJ, Zhang S, Zhou H, Stoica L, Galiano M, Krnjevic K, Roman G et al (2013) mTORC2 controls actin polymerization required for consolidation of long-term memory. Nat Neurosci 16:441\u2013448","journal-title":"Nat Neurosci"},{"key":"956_CR65","doi-asserted-by":"publisher","first-page":"8432","DOI":"10.1523\/JNEUROSCI.1105-14.2014","volume":"34","author":"F Lebrun-Julien","year":"2014","unstructured":"Lebrun-Julien F, Bachmann L, Norrmen C, Trotzmuller M, Kofeler H, Ruegg MA, Hall MN, Suter U (2014) Balanced mTORC1 activity in oligodendrocytes is required for accurate CNS myelination. J Neurosci 34:8432\u20138448","journal-title":"J Neurosci"},{"key":"956_CR66","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.devcel.2006.08.013","volume":"11","author":"C Shiota","year":"2006","unstructured":"Shiota C, Woo JT, Lindner J, Shelton KD, Magnuson MA (2006) Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. Dev Cell 11:583\u2013589","journal-title":"Dev Cell"},{"key":"956_CR67","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1128\/MCB.00306-14","volume":"35","author":"S Wang","year":"2015","unstructured":"Wang S, Amato KR, Song W, Youngblood V, Lee K, Boothby M, Brantley-Sieders DM, Chen J (2015) Regulation of endothelial cell proliferation and vascular assembly through distinct mTORC2 signaling pathways. Mol Cell Biol 35:1299\u20131313","journal-title":"Mol Cell Biol"},{"key":"956_CR68","doi-asserted-by":"publisher","first-page":"11299","DOI":"10.1523\/JNEUROSCI.5910-11.2012","volume":"32","author":"X Chen","year":"2012","unstructured":"Chen X, Tagliaferro P, Kareva T, Yarygina O, Kholodilov N, Burke RE (2012) Neurotrophic effects of serum- and glucocorticoid-inducible kinase on adult murine mesencephalic dopamine neurons. J Neurosci 32:11299\u201311308","journal-title":"J Neurosci"},{"key":"956_CR69","first-page":"1282","volume":"6","author":"X Wu","year":"2013","unstructured":"Wu X, Mao H, Liu J, Xu J, Cao J, Gu X, Cui G (2013) Dynamic change of SGK expression and its role in neuron apoptosis after traumatic brain injury. Int J Clin Exp Pathol 6:1282\u20131293","journal-title":"Int J Clin Exp Pathol"},{"key":"956_CR70","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s13238-010-0123-x","volume":"1","author":"D Gao","year":"2010","unstructured":"Gao D, Wan L, Wei W (2010) Phosphorylation of Rictor at Thr1135 impairs the Rictor\/Cullin-1 complex to ubiquitinate SGK1. Protein Cell 1:881\u2013885","journal-title":"Protein Cell"},{"key":"956_CR71","doi-asserted-by":"publisher","first-page":"5924","DOI":"10.4049\/jimmunol.1303495","volume":"193","author":"D Smrz","year":"2014","unstructured":"Smrz D, Cruse G, Beaven MA, Kirshenbaum A, Metcalfe DD, Gilfillan AM (2014) Rictor negatively regulates high-affinity receptors for IgE-induced mast cell degranulation. J Immunol 193:5924\u20135932","journal-title":"J Immunol"},{"key":"956_CR72","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/ki.2013.559","volume":"86","author":"J Li","year":"2014","unstructured":"Li J, Xu Z, Jiang L, Mao J, Zeng Z, Fang L, He W, Yuan W et al (2014) Rictor\/mTORC2 protects against cisplatin-induced tubular cell death and acute kidney injury. Kidney Int 86:86\u2013102","journal-title":"Kidney Int"},{"key":"956_CR73","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1002\/jnr.21258","volume":"85","author":"JM Garcia-Martinez","year":"2007","unstructured":"Garcia-Martinez JM, Perez-Navarro E, Xifro X, Canals JM, Diaz-Hernandez M, Trioulier Y, Brouillet E, Lucas JJ et al (2007) BH3-only proteins Bid and Bim(EL) are differentially involved in neuronal dysfunction in mouse models of Huntington\u2019s disease. J Neurosci Res 85:2756\u20132769","journal-title":"J Neurosci Res"},{"key":"956_CR74","doi-asserted-by":"publisher","first-page":"30240","DOI":"10.1074\/jbc.M112.374405","volume":"287","author":"M Urbanska","year":"2012","unstructured":"Urbanska M, Gozdz A, Swiech LJ, Jaworski J (2012) Mammalian target of rapamycin complex 1 (mTORC1) and 2 (mTORC2) control the dendritic arbor morphology of hippocampal neurons. J Biol Chem 287:30240\u201330256","journal-title":"J Biol Chem"},{"key":"956_CR75","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.neuron.2011.10.012","volume":"72","author":"MS Mazei-Robison","year":"2011","unstructured":"Mazei-Robison MS, Koo JW, Friedman AK, Lansink CS, Robison AJ, Vinish M, Krishnan V, Kim S et al (2011) Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neurons. Neuron 72:977\u2013990","journal-title":"Neuron"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-0956-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-0956-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-0956-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T21:02:38Z","timestamp":1550523758000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-0956-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,19]]},"references-count":75,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["956"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-0956-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,19]]},"assertion":[{"value":"31 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were performed in compliance with the NIH Guide for the Care and Use of Laboratory Animals and approved by the local animal care committee of Universitat de Barcelona following European (2010\/63\/UE) and Spanish (RD53\/2013) regulations for the care and use of laboratory animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Human samples were obtained following the guidelines and approval of the local ethics committee (Hospital Cl\u00ednic of Barcelona\u2019s Clinical Research Ethics Committee).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}